Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.inogen.com

Address:

859 Ward Drive, Goleta, United States

OfficialStocktwitsUser Feb. 22 at 2:02 AM

$INGN RSI: 46.71, MACD: -0.1652 Vol: 0.14, MA20: 5.84, MA50: 6.35 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 18 at 2:31 PM

$INGN Current Stock Price: $5.70 Contracts to trade: $5.0 INGN Feb 20 2026 Call Entry: $0.72 Exit: $0.91 ROI: 26% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

GlassBreaker Feb. 18 at 8:16 AM

$INGN Inogen provides portable oxygen concentrators, facing reimbursement pressure and competitive markets with post-pandemic demand reset [citation:historical].

0 · Reply

RocketThief Feb. 11 at 6:53 PM

$INGN oasis in a sea of misery today

0 · Reply

zecca1889 Feb. 6 at 4:44 PM

$INGN But what is the curse on this stock?

0 · Reply

ZacksResearch Feb. 2 at 4:33 PM

Is $INGN a hidden gem in the POC market? 🤔 Despite a recent 9.8% share decline, Inogen's expansive product lineup and strategic partnerships position it for growth, with a projected 46.3% earnings increase and 12.2% revenue improvement for 2026. 📈 See why Inogen's prospects might be undervalued 👉 https://www.zacks.com/stock/news/2827087/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2827087-body-31490&ADID=SYND_STOCKTWITS_TWEET_2_2827087_BODY_31490

0 · Reply

ZacksResearch Feb. 2 at 3:33 PM

Here’s why $INGN could be a timely add right now 👀 Q3 revenue rose 4% as portable oxygen concentrator (POC) demand grew, and the stock is trading at a low valuation — even with seasonal softness in the quarter. Is this a setup for a rebound? Full investment case here 👉 https://www.zacks.com/stock/news/2827087/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2827087-teaser-31479&ADID=SYND_STOCKTWITS_TWEET_2_2827087_TEASER_31479

0 · Reply

markusann Jan. 30 at 11:34 PM

$INGN lots of insider and institutional buying

0 · Reply

zecca1889 Jan. 30 at 4:30 PM

$INGN we are at an all-time low, what a shame

0 · Reply

RocketThief Jan. 22 at 5:51 PM

$INGN ok, so EV of $48M with no debt and $125M in cash, annual guidance of $349M in sales, small positive cash flow in Q3, rolling out new products. Growth is very modest but this seems like a great entry point

0 · Reply

Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Jan 7, 2026, 8:30 AM EST - 6 weeks ago

Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

Nov 11, 2025, 3:01 PM EST - 3 months ago

Slow Progress At Inogen

Nov 5, 2025, 5:01 PM EST - 3 months ago

Inogen, Inc. (INGN) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:30 AM EST - 3 months ago

Inogen Announces Third Quarter 2025 Financial Results

Oct 15, 2025, 8:30 AM EDT - 4 months ago

Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025

Sep 25, 2025, 4:05 PM EDT - 5 months ago

Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

Aug 8, 2025, 6:18 PM EDT - 7 months ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Inogen Announces Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 7 months ago

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 23, 2025, 8:30 AM EDT - 8 months ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

May 22, 2025, 1:38 PM EDT - 9 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 10 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 10 months ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 1 year ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 1 year ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 1 year ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 1 year ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 1 year ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 1 year ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 1 year ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 2 years ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 2 years ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 2 years ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 2 years ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 2 years ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 2 years ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 2 years ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 2 years ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 2 years ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 7, 2023, 11:08 PM EST - 2 years ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 2 years ago

Inogen Announces Third Quarter 2023 Financial Results

Oct 10, 2023, 4:00 PM EDT - 2 years ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist

OfficialStocktwitsUser Feb. 22 at 2:02 AM

0 · Reply

BillionerOfKing Feb. 18 at 2:31 PM

0 · Reply

GlassBreaker Feb. 18 at 8:16 AM

$INGN Inogen provides portable oxygen concentrators, facing reimbursement pressure and competitive markets with post-pandemic demand reset [citation:historical].

0 · Reply

RocketThief Feb. 11 at 6:53 PM

$INGN oasis in a sea of misery today

0 · Reply

zecca1889 Feb. 6 at 4:44 PM

$INGN But what is the curse on this stock?

0 · Reply

ZacksResearch Feb. 2 at 4:33 PM

0 · Reply

ZacksResearch Feb. 2 at 3:33 PM

0 · Reply

markusann Jan. 30 at 11:34 PM

$INGN lots of insider and institutional buying

0 · Reply

zecca1889 Jan. 30 at 4:30 PM

$INGN we are at an all-time low, what a shame

0 · Reply

RocketThief Jan. 22 at 5:51 PM

0 · Reply

Jorwax Jan. 22 at 12:05 AM

2026 rebounds $SFM $INGN $HUBS $BOX

0 · Reply

SuperGreenToday Jan. 19 at 7:14 PM

$INGN Share Price: $6.24 Contract Selected: Jun 18, 2026 $5 Calls Buy Zone: $1.27 – $1.58 Target Zone: $2.38 – $2.91 Potential Upside: 77% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

OfficialStocktwitsUser Jan. 15 at 7:57 PM

$INGN RSI: 45.71, MACD: -0.1228 Vol: 0.27, MA20: 6.72, MA50: 6.87 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DARKP00L Jan. 12 at 5:10 PM

$INGN 12:09 on Jan. 12 2026 Inogen shares are trading lower after the company lowered its Q4 and FY25 sales guidance. #tradeideas

0 · Reply

zecca1889 Jan. 12 at 2:58 PM

$INGN what an exaggeration

0 · Reply

ZacksResearch Jan. 8 at 2:49 PM

New product, new market — is this the catalyst $INGN needed? 👀 INGN shares moved higher after launching Aurora CPAP masks, expanding its respiratory care suite and opening the door to the growing sleep apnea market. Does this launch change the growth outlook? Full details here 👉 https://www.zacks.com/stock/news/2814283/ingn-stock-gains-post-latest-launch-to-expand-respiratory-care-suite?cid=sm-stocktwits-2-2814283-teaser-27946&ADID=SYND_STOCKTWITS_TWEET_2_2814283_TEASER_27946

0 · Reply

ZacksResearch Jan. 8 at 1:49 PM

$INGN up nearly 7.8% following CPAP mask launch — bullish or a temporary bump? 🚀 🛏️ New Aurora CPAP masks expand product line & target sleep apnea market. 📈 INGN's P/S ratio of 0.6 compared with industry’s 3.9. Discover the potential impact on INGN’s market position here 👉 https://www.zacks.com/stock/news/2814283/ingn-stock-gains-post-latest-launch-to-expand-respiratory-care-suite?cid=sm-stocktwits-2-2814283-body-27941&ADID=SYND_STOCKTWITS_TWEET_2_2814283_BODY_27941

0 · Reply

DARKP00L Jan. 7 at 1:36 PM

$INGN 08:33 on Jan. 07 2026 Inogen shares are trading higher after the company launched its Aurora CPAP masks in the US. #tradeideas

0 · Reply

DARKP00L Jan. 7 at 1:36 PM

$INGN 08:33 on Jan. 07 2026 Inogen Launches Aurora CPAP Masks In The US #tradeideas

0 · Reply

ZacksResearch Jan. 2 at 3:03 PM

Inogen ($INGN) poised for growth despite 10.3% stock dip in 6 months against industry growth of 5.2%! 📉 ⚡️ Projected 37.8% earnings growth for 2026 🛠️ Expanding product portfolio, including new Simeox device 🌍 Strategic partnerships bolster international reach Discover the details here 👉 https://www.zacks.com/stock/news/2811239/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2811239-body-27111&ADID=SYND_STOCKTWITS_TWEET_2_2811239_BODY_27111

0 · Reply

ZacksResearch Jan. 2 at 2:03 PM

$INGN is heating up — this might be the add investors are looking for. 🚀 Rising POC demand, new product launches, and strong Q3 sales are driving momentum, even as competition and forex swings temper near-term growth. See why Inogen could be worth adding now 👉 https://www.zacks.com/stock/news/2811239/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2811239-teaser-27110&ADID=SYND_STOCKTWITS_TWEET_2_2811239_TEASER_27110

0 · Reply

BillionerOfKing Dec. 26 at 9:56 PM

$INGN Current Stock Price: $6.80 Contracts to trade: $7.5 INGN Jan 16 2026 Call Entry: $0.14 Exit: $0.26 ROI: 89% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

1 · Reply

Market Cap	157.19M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.69%
Debt to Equity Ratio	0.00

Volume	175,900
Avg Vol	203,308
Day's Range	N/A - N/A
Shares Out	27.15M
Stochastic %K	40%
Beta	1.79
Analysts	Sell
Price Target	$13.00